These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25300371)

  • 1. Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients.
    Ishimura E; Okuno S; Okazaki H; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
    Kidney Blood Press Res; 2014; 39(4):299-307. PubMed ID: 25300371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.
    Nakashima A; Yorioka N; Mizutani T; Yamagata Z; Ueno T; Takasugi N
    Nephron Clin Pract; 2005; 99(3):c78-85. PubMed ID: 15665550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma serotonin and markers of bone formation and bone resorption in hemodialysis patients.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Sparopoulou T; Stefanidis I; Galaktidou G
    Iran J Kidney Dis; 2013 Jan; 7(1):36-41. PubMed ID: 23314140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
    Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
    Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC
    J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I; Balon BP; Rus I; Marc J
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
    Woitge HW; Scheidt-Nave C; Kissling C; Leidig-Bruckner G; Meyer K; Grauer A; Scharla SH; Ziegler R; Seibel MJ
    J Clin Endocrinol Metab; 1998 Jan; 83(1):68-75. PubMed ID: 9435418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients.
    Takahashi N; Kojima T; Ogawa H; Ishiguro N
    Nephrology (Carlton); 2007 Dec; 12(6):539-45. PubMed ID: 17995578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics.
    Rogers RS; Dawson AW; Wang Z; Thyfault JP; Hinton PS
    J Appl Physiol (1985); 2011 Nov; 111(5):1353-60. PubMed ID: 21868687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal telopeptide of type I collagen, osteocalcin, alkaline phosphatase, and parathyroid hormone in healthy and hospitalized foals.
    Kamr AM; Dembek KA; Gilsenan W; Bozorgmanesh R; Hassan HY; Rosol TJ; Toribio RE
    Domest Anim Endocrinol; 2020 Jul; 72():106470. PubMed ID: 32408050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
    Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
    Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.